697 results on '"De Ferrari, Gaetano M."'
Search Results
2. Rationale and design of the effect of evolocumab in patients at high cardiovascular risk without prior myocardial infarction or stroke (VESALIUS-CV) trial
3. Prognostic impact of atrial rhythm and dimension in patients with structural heart disease undergoing cardiac sympathetic denervation for ventricular arrhythmias.
4. Prognostic implications of impaired longitudinal left ventricular systolic function assessed by tissue Doppler imaging prior to transcatheter aortic valve implantation for severe aortic stenosis
5. Impact of computed-tomography defined sarcopenia on outcomes of older adults undergoing transcatheter aortic valve implantation
6. Left Cardiac Sympathetic Denervation for Long QT Syndrome: 50 Years’ Experience Provides Guidance for Management
7. Pretransplant Right Ventricular Dysfunction Is Associated With Increased Mortality After Heart Transplantation: A Hard Inheritance to Overcome
8. Implantation of cardiac electronic devices in active COVID-19 patients: Results from an international survey
9. OPTImal PHARMacological therapy for patients with heart failure: Rationale and design of the OPTIPHARM‐HF registry.
10. Comparison of antithrombotic strategies in patients with cryptogenic stroke and patent foramen ovale: an updated meta-analysis
11. Long-Term Efficacy of Evolocumab in Patients With or Without Multivessel Coronary Disease
12. Autonomic Regulation Therapy To Improve Symptoms And Clinical Outcomes In Patients With Heart Failure And Reduced Ejection Fraction (ANTHEM-HFrEF) Pivotal Study Results
13. Prognostic Implications of a Novel Algorithm to Grade Secondary Tricuspid Regurgitation
14. Right Ventricular–Pulmonary Arterial Coupling in Secondary Tricuspid Regurgitation
15. Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection
16. Mortality Risk Assessment Using CHA(2)DS(2)-VASc Scores in Patients Hospitalized With Coronavirus Disease 2019 Infection
17. Meta-Analysis Comparing P2Y12 Inhibitors in Acute Coronary Syndrome
18. Early Complete Revascularization in Hemodynamically Stable Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease
19. Validation of the return of spontaneous circulation after cardiac arrest (RACA) score in two different national territories
20. Adverse events of colchicine for cardiovascular diseases: a comprehensive meta-analysis of 14 188 patients from 21 randomized controlled trials
21. Use of guideline-recommended management in established coronary heart disease in the observational DYSIS II study
22. In-hospital outcomes in nonagenarian patients undergoing primary percutaneous coronary intervention
23. Digoxin and Mortality in Patients With Atrial Fibrillation
24. Impact of stent thickness on clinical outcomes in small vessel and bifurcation lesions: a RAIN-CARDIOGROUP VII sub-study
25. Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
26. End-tidal carbon dioxide and defibrillation success in out-of-hospital cardiac arrest
27. Prognostic Impact of in-Hospital-Bleeding in Patients With ST-Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention
28. Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II
29. Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
30. Long-term vagal stimulation for heart failure: Eighteen month results from the NEural Cardiac TherApy foR Heart Failure (NECTAR-HF) trial
31. Atrial fibrillation ablation long-term ESC-EHRA EORP AFA LT registry: in-hospital and 1-year follow-up findings in Italy
32. Vagal Stimulation in Heart Failure: An Anti-inflammatory Intervention?
33. Appraising features and outlook of women and men discharged after an acute coronary syndrome: evidence from the 23,700-patient PRAISE International Registry.
34. Duration and kind of dual antiplatelet therapy for acute coronary syndrome patients: a network meta-analysis.
35. Inpatient Mortality According to Level of Respiratory Support Received for Severe Acute Respiratory Syndrome Coronavirus 2 (Coronavirus Disease 2019) Infection: A Prospective Multicenter Study
36. Late atrial arrhythmias after lung transplantation: a meta-analysis
37. The unfavourable inflammatory response in elderly patients after myocardial infarction: should we talk of ‘dysflammaging’?
38. Association Between Achieved Low-Density Lipoprotein Cholesterol Levels and Long-Term Cardiovascular and Safety Outcomes: An Analysis of FOURIER-OLE
39. Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with TAVR
40. OCT guided vs. COmplete pci in patieNts with sT segment elevation myocArdial infarCtion and mulTivessel disease: OCT-CONTACT RCT
41. Safety and Efficacy of Bempedoic Acid: A Systematic Review and Metanalysis of Randomised Controlled Trials
42. Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry
43. Safety and efficacy of ezetimibe: A meta-analysis
44. Available oral lipid-lowering agents could bring most high-risk patients to target: an estimate based on the Dyslipidemia International Study II-Italy
45. Left main coronary artery external compression by lung adenocarcinoma successfully treated with percutaneous coronary intervention
46. SCAI stage reclassification at 24 h predicts outcome of cardiogenic shock: Insights from the Altshock‐2 registry
47. PREDESTINATION: PRimary vEntricular fibrillation and suDden dEath during a firST myocardIal iNfArcTION: Genetic Basis
48. Current challenges for clinical trials of cardiovascular medical devices
49. Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
50. Abstract 20851: Incidence of Appropriate ICD Therapies After Elective Generator Replacement in Patient With Heart Failure Initially Implanted for Primary Prevention: A Systematic Literature Review and Metanalysis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.